Search Results for: test services
PR Newswire Transaction to enhance Labcorp’s laboratory services network and expand access to the company’s high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI, March 28, 2024 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select […]
12
Feb
Feb
February is American Heart Month, a time to raise awareness about heart health and encourage everyone to take steps to prevent heart disease. At BioReference Health®, we are dedicated to supporting heart health and empowering individuals to prioritize their cardiovascular well-being. Through cutting-edge diagnostic testing, personalized wellness offerings, and educational resources, we are honored to […]
06
Feb
Feb
As we come together to recognize World Cancer Day in February 2024, it’s important to acknowledge the significant strides being made in cancer care. (123) BioReference continues to be at the forefront of these efforts, demonstrating a steadfast commitment to advancing oncology testing, tailored precision medicine, collaborative care and support, advancements in cancer research, and […]
Press Release
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
07
Nov
Nov
World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON, MA, ELMWOOD PARK, NJ, and Rolle, Switzerland, November 7, 2023 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that […]
17
Nov
Nov
You might have noticed an update in our name from BioReference Laboratories, Inc. to BioReference Health, LLC. While it may be a small shift in what we call ourselves, our new identity represents a significant difference in how we deliver our solutions and services. For more than four decades, BioReference has built a legacy based […]
Press Release
Aspira Women’s Health Announces Formal Launch of Co-Marketing and Distribution Collaboration with BioReference
05
Oct
Oct
Aspira Women’s Health Inc. OVA1Plus® now available to an expanded network of physicians, supporting patients nationwide AUSTIN, Texas, Oct. 05, 2022 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the formal launch of its co-marketing and distribution collaboration with BioReference®, an OPKO Health […]
10
May
May
Mother’s Day kicks off a special health observance each year – National Women’s Health Week. Driven by the U.S. Department of Health and Human Services’ Office on Women’s Health, this annual initiative encourages women of all ages to check in on their individual health needs. Here, we’re breaking down information about some common health concerns […]
02
May
May
Effective May 2nd, GeneDx, formerly a subsidiary of BioReference, has been acquired by Sema4. We’d like to take a moment to reflect on the work that BioReference and GeneDx have accomplished together – helping hundreds of thousands of patients benefit from genomic information to make important health decisions. At BioReference | GenPath, we remain committed to […]
